BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 22710717)

  • 21. Protein tyrosine phosphatase PTPN3 inhibits lung cancer cell proliferation and migration by promoting EGFR endocytic degradation.
    Li MY; Lai PL; Chou YT; Chi AP; Mi YZ; Khoo KH; Chang GD; Wu CW; Meng TC; Chen GC
    Oncogene; 2015 Jul; 34(29):3791-803. PubMed ID: 25263444
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A synthetic form of frizzled 8-associated antiproliferative factor enhances p53 stability through USP2a and MDM2.
    Kim J; Keay SK; You S; Loda M; Freeman MR
    PLoS One; 2012; 7(12):e50392. PubMed ID: 23236372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of EGFR trafficking and cell signaling by Sprouty2 and MIG6 in lung cancer cells.
    Walsh AM; Lazzara MJ
    J Cell Sci; 2013 Oct; 126(Pt 19):4339-48. PubMed ID: 23868981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma.
    Zhang H; Han B; Lu H; Zhao Y; Chen X; Meng Q; Cao M; Cai L; Hu J
    Cancer Lett; 2018 Oct; 433():186-198. PubMed ID: 29981430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endosomal deubiquitinating enzymes control ubiquitination and down-regulation of protease-activated receptor 2.
    Hasdemir B; Murphy JE; Cottrell GS; Bunnett NW
    J Biol Chem; 2009 Oct; 284(41):28453-28466. PubMed ID: 19684015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. USP9X Controls EGFR Fate by Deubiquitinating the Endocytic Adaptor Eps15.
    Savio MG; Wollscheid N; Cavallaro E; Algisi V; Di Fiore PP; Sigismund S; Maspero E; Polo S
    Curr Biol; 2016 Jan; 26(2):173-183. PubMed ID: 26748853
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recruitment of Uev1B to Hrs-containing endosomes and its effect on endosomal trafficking.
    Duex JE; Mullins MR; Sorkin A
    Exp Cell Res; 2010 Aug; 316(13):2136-51. PubMed ID: 20420830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EGFR over-expression in non-small cell lung cancers harboring EGFR mutations is associated with marked down-regulation of CD82.
    Yang CH; Chou HC; Fu YN; Yeh CL; Cheng HW; Chang IC; Liu KJ; Chang GC; Tsai TF; Tsai SF; Liu HP; Wu YC; Chen YT; Huang SF; Chen YR
    Biochim Biophys Acta; 2015 Jul; 1852(7):1540-9. PubMed ID: 25912735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. USP2a positively regulates TCR-induced NF-κB activation by bridging MALT1-TRAF6.
    Li Y; He X; Wang S; Shu HB; Liu Y
    Protein Cell; 2013 Jan; 4(1):62-70. PubMed ID: 23264041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src.
    Chung BM; Raja SM; Clubb RJ; Tu C; George M; Band V; Band H
    BMC Cell Biol; 2009 Nov; 10():84. PubMed ID: 19948031
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assess the expression of ubiquitin specific protease USP2a for bladder cancer diagnosis.
    Jeong P; Ha YS; Yun SJ; Yoon HY; Freeman MR; Kim J; Kim WJ
    BMC Urol; 2015 Aug; 15():80. PubMed ID: 26250800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological significance of ubiquitin-specific protease 2a (USP2a), fatty acid synthase (FASN), and ErbB2 expression in oral squamous cell carcinomas.
    da Silva SD; Cunha IW; Nishimoto IN; Soares FA; Carraro DM; Kowalski LP; Graner E
    Oral Oncol; 2009 Oct; 45(10):e134-9. PubMed ID: 19362044
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EGF receptor ubiquitination is not necessary for its internalization.
    Huang F; Goh LK; Sorkin A
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):16904-9. PubMed ID: 17940017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defective ubiquitinylation of EGFR mutants of lung cancer confers prolonged signaling.
    Shtiegman K; Kochupurakkal BS; Zwang Y; Pines G; Starr A; Vexler A; Citri A; Katz M; Lavi S; Ben-Basat Y; Benjamin S; Corso S; Gan J; Yosef RB; Giordano S; Yarden Y
    Oncogene; 2007 Oct; 26(49):6968-78. PubMed ID: 17486068
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF.
    Mahul-Mellier AL; Pazarentzos E; Datler C; Iwasawa R; AbuAli G; Lin B; Grimm S
    Cell Death Differ; 2012 May; 19(5):891-9. PubMed ID: 22179575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High Ubiquitin-Specific Protease 2a Expression Level Predicts Poor Prognosis in Upper Tract Urothelial Carcinoma.
    Ke HL; Lee YC; Li WM; Wang CS; Hsu WC; Lin HH; Lee YA; Jhan JH; Li CC; Yeh HC; Wu WJ; Huang AM
    Appl Immunohistochem Mol Morphol; 2022 Apr; 30(4):304-310. PubMed ID: 35384881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diminished functional role and altered localization of SHP2 in non-small cell lung cancer cells with EGFR-activating mutations.
    Furcht CM; Muñoz Rojas AR; Nihalani D; Lazzara MJ
    Oncogene; 2013 May; 32(18):2346-55, 2355.e1-10. PubMed ID: 22777356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP17 is required for clathrin mediated endocytosis of epidermal growth factor receptor.
    Jaworski J; de la Vega M; Fletcher SJ; McFarlane C; Greene MK; Smyth AW; Van Schaeybroeck S; Johnston JA; Scott CJ; Rappoport JZ; Burrows JF
    Oncotarget; 2014 Aug; 5(16):6964-75. PubMed ID: 25026282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational activation of the epidermal growth factor receptor down-regulates major histocompatibility complex class I expression via the extracellular signal-regulated kinase in non-small cell lung cancer.
    Watanabe S; Hayashi H; Haratani K; Shimizu S; Tanizaki J; Sakai K; Kawakami H; Yonesaka K; Tsurutani J; Togashi Y; Nishio K; Ito A; Nakagawa K
    Cancer Sci; 2019 Jan; 110(1):52-60. PubMed ID: 30390416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CHMP1B is a target of USP8/UBPY regulated by ubiquitin during endocytosis.
    Crespo-Yàñez X; Aguilar-Gurrieri C; Jacomin AC; Journet A; Mortier M; Taillebourg E; Soleilhac E; Weissenhorn W; Fauvarque MO
    PLoS Genet; 2018 Jun; 14(6):e1007456. PubMed ID: 29933386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.